Shanghai - Delayed Quote CNY

GYBYS (600332.SS)

26.89
+0.10
+(0.37%)
At close: 3:00:03 PM GMT+8
Loading Chart for 600332.SS
  • Previous Close 26.79
  • Open 26.71
  • Bid 26.88 x --
  • Ask 26.89 x --
  • Day's Range 26.63 - 26.94
  • 52 Week Range 24.30 - 33.72
  • Volume 3,754,101
  • Avg. Volume 6,960,354
  • Market Cap (intraday) 41.306B
  • Beta (5Y Monthly) 0.52
  • PE Ratio (TTM) 16.20
  • EPS (TTM) 1.66
  • Earnings Date Apr 29, 2025
  • Forward Dividend & Yield 1.15 (4.29%)
  • Ex-Dividend Date Oct 25, 2024
  • 1y Target Est --

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical equipment, and healthcare products; and research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical services, health management, health maintenance, elderly care, etc.; and provides leasing and commercial, health, advertising, loading offloading, and warehouse services. It operates through retail chain pharmacy stores and retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.

www.gybys.com.cn

28,138

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 600332.SS

View More

Performance Overview: 600332.SS

Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

600332.SS
5.38%
SSE Composite Index (000001.SS)
0.47%

1-Year Return

600332.SS
14.30%
SSE Composite Index (000001.SS)
6.77%

3-Year Return

600332.SS
1.59%
SSE Composite Index (000001.SS)
8.74%

5-Year Return

600332.SS
3.49%
SSE Composite Index (000001.SS)
16.18%

Compare To: 600332.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 600332.SS

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    41.15B

  • Enterprise Value

    41.16B

  • Trailing P/E

    16.14

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.58

  • Price/Book (mrq)

    1.15

  • Enterprise Value/Revenue

    0.55

  • Enterprise Value/EBITDA

    10.83

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.62%

  • Return on Assets (ttm)

    2.60%

  • Return on Equity (ttm)

    7.21%

  • Revenue (ttm)

    74.52B

  • Net Income Avi to Common (ttm)

    2.7B

  • Diluted EPS (ttm)

    1.66

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    18.54B

  • Total Debt/Equity (mrq)

    36.63%

  • Levered Free Cash Flow (ttm)

    521.38M

Research Analysis: 600332.SS

View More

Company Insights: 600332.SS

Research Reports: 600332.SS

View More

People Also Watch